RT Journal Article
SR Electronic
T1 Cell graph neural networks enable the digital staging of tumor microenvironment and precise prediction of patient survival in gastric cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.01.21262086
DO 10.1101/2021.09.01.21262086
A1 Wang, Yanan
A1 Wang, Yu Guang
A1 Hu, Changyuan
A1 Li, Ming
A1 Fan, Yanan
A1 Otter, Nina
A1 Sam, Ikuan
A1 Gou, Hongquan
A1 Hu, Yiqun
A1 Kwok, Terry
A1 Zalcberg, John
A1 Boussioutas, Alex
A1 Daly, Roger J.
A1 Montúfar, Guido
A1 Liò, Pietro
A1 Xu, Dakang
A1 Webb, Geoffrey I.
A1 Song, Jiangning
YR 2021
UL http://medrxiv.org/content/early/2021/09/14/2021.09.01.21262086.abstract
AB Gastric cancer is one of the deadliest cancers worldwide. Accurate prognosis is essential for effective clinical assessment and treatment. Spatial patterns in the tumor microenvironment (TME) are conceptually indicative of the staging and progression of gastric cancer patients. Using spatial patterns of the TME by integrating and transforming the multiplexed immunohistochemistry (mIHC) images as Cell-Graphs, we propose a novel graph neural network-based approach, termed Cell-Graph Signature or CGSignature, powered by artificial intelligence, for digital staging of TME and precise prediction of patient survival in gastric cancer. In this study, patient survival prediction is formulated as either a binary (short-term and long-term) or ternary (short-term, medium-term, and long-term) classification task. Extensive benchmarking experiments demonstrate that the CGSignature achieves outstanding model performance, with Area Under the Receiver-Operating Characteristic curve (AUROC) of 0.960±0.01, and 0.771±0.024 to 0.904±0.012 for the binary- and ternary-classification, respectively. Moreover, Kaplan-Meier survival analysis indicates that the ‘digital-grade’ cancer staging produced by CGSignature provides a remarkable capability in discriminating both binary and ternary classes with statistical significance (p-value < 0.0001), significantly outperforming the AJCC 8th edition Tumor-Node-Metastasis staging system. Using Cell-Graphs extracted from mIHC images, CGSignature improves the assessment of the link between the TME spatial patterns and patient prognosis. Our study suggests the feasibility and benefits of such artificial intelligence-powered digital staging system in diagnostic pathology and precision oncology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Major Inter-Disciplinary Research (IDR) Grant awarded by Monash UniversityAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Shanghai Ruijin Hospital under protocol 2021SQ015. All researchers were blinded to the patient private data during the experimental analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used for the main analyses presented here is available for non-commercial use and can be accessible by request.